Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Santa rally? Three midcap stocks to consider buying on Tuesday

    • Private sector filling up the vacuum in healthcare facilities: Wockhardt

    • Aim to become a research-based co in 10 years; no plans to sell assets: Wockhardt

    • Hindustan Tin Works expect to cross Rs 300 crore topline in FY18

    • Will continue to do well in UK & Indian markets: Wockhardt

    • Cash ban, Brexit weigh heavy; expect normalcy in Q4: Wockhardt

    • No scope of US intervention in Indian pharma cos: Wockhardt

    • Pharma sector sales down 10-12%, pain to ease by Jan: Wockhardt

    • CP Pharma under FDA lens, will reply in 3 weeks: Wockhardt Chief

    • Wockhardt receives US FDA's establishment inspection report

    • Aim is to prevent rampant use of antibiotics: P Lilladher

    • R&D tax deduction unlikely to impact Wockhardt: CEO

    • See double-digit sales growth across markets in FY17: Wockhardt

    • All 9 USFDA observations will be resolved in 3 months: Wockhardt

    • Will not do any out-licensing in near-term: Wockhardt

    • Eye 15-20% revenue growth from US biz: Wockhardt

    • No grave observations made in USFDA Waluj visit: Wockhardt

    • Meet the Khorakiwalas: Gen-Next promoters of Wockhardt

    • See capex of Rs 500cr in next 3-4 yrs: Wockhardt Hospitals

    • Will take 2-2.5 yrs for phase-3 clinical trails: Wockhardt

    • India's pharma industry seeing rapid growth: Wockhardt

    • Need to be watchful of FDA import alert pattern: Dandekar

    • Taking corrrective measures on regulatory issues: Wockhardt

      Paracetamol is a very important anti-fever and painkiller, which has a large domestic production. India consumes about 10,000 tonnes of the drug in one year, says Dr Habil F Khorakiwala of Wockhardt .

    • Q2 earnings hit by recent regulatory actions: Wockhardt

      As the drug regulators tighten their noose, Wockhardt stock has been volatile and investors are wary of the company's recovery.

    • PAT boost on low debt-equity, high interest: Wockhardt

      Wockhardt chairman Habil Khorakiwala explains to CNBC-TV18's Archana Shukla that the PAT will get a boost on low debt-equity ratio, and high interest rates.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347